Login / Signup

Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN study.

James LucocqJake HawkyardBeate HaugkOmar MownahKrishna MenonTakaki FurukawaYosuke InoueYuki HiroseNaoki SasahiraMichael FeretisAnita BalakrishnanCarlo CeresaBrian DavidsonRupaly PandeBobby DasariLulu TannoDimitrios KaraviasJack HelliwellAlistair YoungQuentin M NunesTomas UrbonasMichael SilvaAlex Gordon-WeeksJenifer BarrieDhanny GomezStijn Van LaarhovenFrancis RobertsonHossain NawaraJoseph DoyleRicky BhogalEwen HarrisonMarcus RoalsoDebora CipraniSomaiah ArooriChathura Bathiya RatnayakeJonathan KoeaGabriele CapursoRuben BellottiStefan StättnerTareq AlsaoudiNeil BhardwajSrujan RajeshFraser JefferySaxon ConnorAndrew CameronNigel B JamiesonAmy SheenAnubhav MittalJas SamraAnthony GillKeith RobertsKjetil SøreideSanjay Pandanaboyana
Published in: The British journal of surgery (2024)
Chemotherapy following resection of adenocarcinoma arising from intraductal papillary mucinous neoplasia does not appear to influence recurrence rates, recurrence patterns or survival.
Keyphrases
  • high grade
  • low grade
  • free survival
  • locally advanced
  • squamous cell carcinoma
  • clinical trial
  • rectal cancer
  • randomized controlled trial
  • radiation therapy